STOCKWATCH
·
Pharmaceuticals
USFDA13 Feb 2024, 11:08 pm

Unichem Labs clears USFDA inspection at Ghaziabad facility

AI Summary

Unichem Laboratories Ltd has informed the stock exchange that the United States Food and Drug Administration (USFDA) conducted an inspection at its Ghaziabad (Uttar Pradesh) formulation facility from February 7, 2024 to February 13, 2024, and the inspection was successfully concluded without any observations. The company takes quality and compliance issues seriously and remains committed to maintaining high standards across all its manufacturing facilities.,

Key Highlights

  • USFDA inspection concluded successfully
  • No observations
  • Company remains committed to quality and compliance
UNICHEMLAB
Pharmaceuticals
UNICHEM LABORATORIES LTD.

Price Impact